Capmatinib - Novartis Oncology
At a glance
- Drug Originator Incyte Corporation
- Drug Licenced by Novartis Oncology
- Drug Class Antineoplastics; Benzamides; Fluorobenzenes; Heterocyclic bicyclo compounds; Imidazoles; Quinolines; Small molecules; Triazines
- Mechanism of Action Proto-oncogene protein c-met inhibitors
- USA Patent Applicants NOVARTIS PHARM
- USA Patents 12
- NDAs 1
- International Patents 174
Table of Contents

Disclaimer